“ Affordability is key. We recently launched a specialty pharmacy network for our portfolio. This allows us to bypass wholesalers and retail pharmacies, reducing our costs ”
In Conversation
Filip Van de Vliet – CEO & Gérard Lefèbvre – Country Head PI Pharmacy Sales & Operations Director, Alter Pharma, Belgium
“ Nowadays, there are a substantial number of drugs unavailable in Belgium, but readily available in other European countries. Through parallel imports, we are able to safely… ”
“ Looking at the longer term, I believe this COVID-19 crisis will have a positive impact on the diagnostics industry by changing the approach countries take towards… ”
“ Sub-Saharan Africa has huge potential, with the population expected to increase by more than one billion by 2050. ”
“ When no bridging process can be found, Pfizer donates the medicines to hospitals that request it. Half of Pfizer’s investments are done through donations, as a… ”
“ Given our status as a raw materials developer, we see an opportunity to expand our offering during this pandemic. Our agility and ability to re-orientate our… ”
Michael Chan – Senior Vice President, Global Issuer Services, Hong Kong Exchanges and Clearing Limited (HKEX)
“ Hong Kong has a unique profile, with both Chinese and international DNA. From a markets point of view, we have demonstrated that our markets are robust… ”
“ The upcoming three years are crucial and UCB Mexico wants to play a role elevating the standard of care in our country ”
“ Oncolytic virus is not necessarily a competitor of standard therapies that are already present in the market such as CAR-T or checkpoint inhibitors. Oncolytic virus works… ”
“ High scientific quality is also really important to us, as well as transparency in our reporting. This way, we aim to contribute to sustainable, accessible and… ”
“ The core business – our research-driven, data-driven approach to innovation – has not changed [post-IPO]. We are committed to developing our portfolio and generating value for… ”
“ We want to see the emergence of an ecosystem of clinical research and position Morocco as an expert hub like other countries such as Tunisia, Egypt… ”